In the present study, we, for the first time, characterized and identified a subpopulation of CD133+ cancer stem-like cells derived from SK-UT-1 (a human ULMS cell line), and demonstrated that CD133 may be as a significant marker for cancer stem-like cells, highlighting its potential role in the treatment of human ULMS. The gene discussed is PROM1; the disease is cancer.